✦ LIBER ✦

The Side Effects of Bacillus Calmette-Guerin in the Treatment of Ta T1 Bladder Cancer Do Not Predict its Efficacy: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial

✍ Scribed by Richard J. Sylvester; Adrian P.M. van der Meijden; Wim Oosterlinck; Wolfgang Hoeltl; Aldo V. Bono

Book ID: 114218729
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 152 KB
Volume: 44
Category: Article
ISSN: 0302-2838
DOI: 10.1016/s0302-2838(03)00371-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The side effects of bacillus calmette-gu

The side effects of bacillus calmette-guerin in the treatment of TA Ti bladder cancer do not predict its efficacy: Results from an eortic genito-urinary group phase III trial

✍ R. Sylvester; A.P.M. Van der Meijden; W. Oosterlinck; G. Casetta; W. Hoeltl; A. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Maintenance Bacillus Calmette-Guerin for

Maintenance Bacillus Calmette-Guerin for Ta T1 Bladder Tumors Is Not Associated with Increased Toxicity: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial

✍ Adrian P.M. van der Meijden; Richard J. Sylvester; Wim Oosterlinck; Wolfgang Hoe 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 105 KB

INTRAVESICAL INSTILLATION OF EPIRUBICIN,

INTRAVESICAL INSTILLATION OF EPIRUBICIN, BACILLUS CALMETTE-GUERIN AND BACILLUS CALMETTE-GUERIN PLUS ISONIAZID FOR INTERMEDIATE AND HIGH RISK TA, T1 PAPILLARY CARCINOMA OF THE BLADDER: A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER GENITO-URINARY GROUP RANDOMIZED PHASE III TRIAL

✍ VAN DER MEIJDEN, ADRIAN P.M.; BRAUSI, MAURIZIO; ZAMBON, VICTOR; KIRKELS, WIM; DE 📂 Article 📅 2001 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 140 KB

BACILLUS CALMETTE-GUERIN VERSUS EPIRUBIC

BACILLUS CALMETTE-GUERIN VERSUS EPIRUBICIN FOR PRIMARY, SECONDARY OR CONCURRENT CARCINOMA IN SITU OF THE BLADDER: RESULTS OF A EUROPEAN ORGANIZATION FOR THE RESEARCH AND TREATMENT OF CANCER—GENITO-URINARY GROUP PHASE III TRIAL (30906)

✍ DEREIJKE, T; KURTH, K; SYLVESTER, R; HALL, R; BRAUSI, M; VANDEBEEK, K; LANDSOGHT 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 86 KB

RE: BACILLUS CALMETTE-GUERIN VERSUS EPIR

RE: BACILLUS CALMETTE-GUERIN VERSUS EPIRUBICIN FOR PRIMARY, SECONDARY OR CONCURRENT CARCINOMA IN SITU OF THE BLADDER: RESULTS OF A EUROPEAN ORGANIZATION FOR THE RESEARCH AND TREATMENT OF CANCER–GENITO-URINARY GROUP PHASE III TRIAL (30906)

✍ Mehraban, Darab; Esfahani, Fatemeh 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 135 KB

Randomized phase II/III trial of interfe

Randomized phase II/III trial of interferon alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell carcinoma: The European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951): Aass N, De Mulder PHM, Mickisch GHJ, Mulders P, van Oosterom AT, van Poppel H, Fossa SD, de Prijck L, Sylvester RJ, Department of Clinical Cancer Research, The Norwegian Radium Hospital, Oslo, Norway

✍ Robert Flanigan 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 42 KB